Literature DB >> 10626712

ACC/AHA guidelines as predictors of postoperative cardiac outcomes.

M J Ali1, P Davison, W Pickett, N S Ali.   

Abstract

PURPOSE: Recently, the American College of Cardiology - American Heart Association (ACC-AHA) published guidelines and an associated algorithm for preoperative cardiovascular evaluation of patients undergoing non-cardiac surgery. Our purpose was to (i) test guideline's ability to predict adverse cardiac events within seven days after surgery, (ii) determine whether medical clinical predictors or surgical risks was a better predictor of cardiac events.
METHODS: Retrospective review of 119 cardiology and anesthesia consultations over 15 mo, ending March 31, 1998. Patients were classified into their respective medical clinical predictor and surgical risk groups, as outlined in ACC-AHA guidelines. Associations between the medical predictor and surgical risk scores and adverse cardiac outcomes were quantified via multiple logistic regression analysis. Two outcomes were employed. Outcome I, included: myocardial infarction/ischemia; angina; congestive heart failure, arrhythmia or death. Outcome 2 expanded the definition to include "cancellation of surgery due to cardiac risk" as a negative cardiac outcome.
RESULTS: Diabetes, Canadian Cardiovascular Class (CCS) III or IV angina, and MI within six months before surgery were strongly associated with the two cardiac outcomes. For outcome 1 and 2, medical predictors and surgical risks, considered simultaneously, performed with a sensitivity of 93% and specificity of 46-51%. When considered separately, major clinical medical predictors had a sensitivity of 87-89%, while surgical risks showed a specificity of 89% in predicting the two outcomes.
CONCLUSION: Medical predictors in ACC-AHA classification scheme were highly sensitive whereas surgical risks were more specific in predicting adverse post-operative cardiac events. Prospective study is needed to confirm these observations.

Entities:  

Mesh:

Year:  2000        PMID: 10626712     DOI: 10.1007/BF03020725

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  5 in total

1.  Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial.

Authors:  Anne Benedicte Juul; Jørn Wetterslev; Christian Gluud; Allan Kofoed-Enevoldsen; Gorm Jensen; Torben Callesen; Peter Nørgaard; Kim Fruergaard; Morten Bestle; Rune Vedelsdal; André Miran; Jon Jacobsen; Jakob Roed; Maj-Britt Mortensen; Lise Jørgensen; Jørgen Jørgensen; Marie-Louise Rovsing; Pernille Lykke Petersen; Frank Pott; Merete Haas; Rikke Albret; Lise Lotte Nielsen; Gun Johansson; Pia Stjernholm; Yvonne Mølgaard; Nikolai Bang Foss; Jeanie Elkjaer; Bjørn Dehlie; Klavs Boysen; Dusanka Zaric; Anne Munksgaard; Jørn Bo Madsen; Bjarne Øberg; Boris Khanykin; Tine Blemmer; Stig Yndgaard; Grazyna Perko; Lars Peter Wang; Per Winkel; Jørgen Hilden; Per Jensen; Nader Salas
Journal:  BMJ       Date:  2006-06-24

2.  Developing a genetic fuzzy system for risk assessment of mortality after cardiac surgery.

Authors:  Mahyar Taghizadeh Nouei; Ali Vahidian Kamyad; MahmoodReza Sarzaeem; Somayeh Ghazalbash
Journal:  J Med Syst       Date:  2014-08-14       Impact factor: 4.460

3.  Influence of type II diabetes mellitus on postoperative complications following colorectal cancer surgery.

Authors:  Răzvan Cătălin Popescu; Nicoleta Leopa; Eugen Dumitru; Anca Florentina Mitroi; Cristina Tocia; Andrei Dumitru; Costel Brînzan; Florin Botea
Journal:  Exp Ther Med       Date:  2022-08-02       Impact factor: 2.751

4.  The Association of Preoperative Frailty and Postoperative Delirium: A Meta-analysis.

Authors:  Thomas J Gracie; Christine Caufield-Noll; Nae-Yuh Wang; Frederick E Sieber
Journal:  Anesth Analg       Date:  2021-08-01       Impact factor: 6.627

Review 5.  The influence of diabetes on postoperative complications following colorectal surgery.

Authors:  D J H Tan; C Y L Yaow; H T Mok; C H Ng; C H Tai; H Y Tham; F J Foo; C S Chong
Journal:  Tech Coloproctol       Date:  2021-01-01       Impact factor: 3.781

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.